BR9811482A - Derivados de 1-(n-fenilaminoalquil)-piperazina substituìda na posição 2 do anel fenìlico - Google Patents
Derivados de 1-(n-fenilaminoalquil)-piperazina substituìda na posição 2 do anel fenìlicoInfo
- Publication number
- BR9811482A BR9811482A BR9811482-4A BR9811482A BR9811482A BR 9811482 A BR9811482 A BR 9811482A BR 9811482 A BR9811482 A BR 9811482A BR 9811482 A BR9811482 A BR 9811482A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- phenylaminoalkyl
- piperazine derivatives
- acyl
- derivatives substituted
- Prior art date
Links
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title abstract 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 title 1
- 125000002252 acyl group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002950 monocyclic group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 208000018360 neuromuscular disease Diseases 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 210000001635 urinary tract Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
Abstract
"DERIVADOS DE 1-(N-FENILAMINOALQUIL)-PIPERAZINA SUBSTITUìDA NA POSIçãO 2 DO ANEL FENìLICO". Derivados de 1-(N-fenilaminoalquil)-piperazina da fórmula: (R = H, alquil-CO, cicloalquil-CO, cicloalquil-CO substituído ou heteroaril-CO monocíclico; R~ 1~ = H ou alquila inferior; R~ 2~ = halogênio, alcóxi, fenóxi, NO~ 2~, CN, acila, NH~ o~, NH(acila), alquil-SO~ 2~NH, alcoxicarbonila, NH~ 2~CO, (alquil)NHCO, (alquil)~ 2~NCO, (acila)NHCO, CF~ 3~ ou polifluoroalcóxi; B = benzilo ou arila mono ou bicíclica ou heteroarila, todos opcionalmente substituídos que ligam-se aos receptores 5HT~ 1A~ e são úteis para tratamento de disfunções neuromusculares do trato urinário inferior. O uso destes compostos para preparação de um medicamento para este tratamento é reivindicado e alguns dos compostos (com valores de B restritos) são reivindicados propriamente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97MI001864A IT1293807B1 (it) | 1997-08-01 | 1997-08-01 | Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico |
PCT/EP1998/004804 WO1999006384A1 (en) | 1997-08-01 | 1998-07-31 | 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9811482A true BR9811482A (pt) | 2002-01-22 |
Family
ID=11377708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9811482-4A BR9811482A (pt) | 1997-08-01 | 1998-07-31 | Derivados de 1-(n-fenilaminoalquil)-piperazina substituìda na posição 2 do anel fenìlico |
Country Status (18)
Country | Link |
---|---|
US (1) | US6071920A (pt) |
EP (1) | EP1000047B1 (pt) |
JP (1) | JP2001512112A (pt) |
KR (1) | KR20010022509A (pt) |
CN (1) | CN1127493C (pt) |
AT (1) | ATE256671T1 (pt) |
AU (1) | AU737456B2 (pt) |
BR (1) | BR9811482A (pt) |
CA (1) | CA2297095A1 (pt) |
DE (1) | DE69820632D1 (pt) |
HU (1) | HUP0004926A3 (pt) |
IL (1) | IL134089A0 (pt) |
IT (1) | IT1293807B1 (pt) |
NO (1) | NO315232B1 (pt) |
NZ (1) | NZ502804A (pt) |
PL (1) | PL338352A1 (pt) |
RU (1) | RU2199533C2 (pt) |
WO (1) | WO1999006384A1 (pt) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399614B1 (en) * | 1997-08-01 | 2002-06-04 | Recordati S.A. Chemical And Pharmaceutical Company | 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring |
US20020193383A1 (en) * | 1997-08-01 | 2002-12-19 | Recordati S.A., Chemical And Pharmaceutical Comoany | 1-(N-phenylalkylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring |
IT1293804B1 (it) | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Diarilalchilpiperazine attive sulle basse vie urinarie |
ATE226932T1 (de) * | 1997-08-04 | 2002-11-15 | Taisho Pharmaceutical Co Ltd | Aryloxyanilin-derivate |
UA62015C2 (en) | 1998-12-28 | 2003-12-15 | Pfizer Prod Inc | Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants) |
US6387909B1 (en) | 1999-07-30 | 2002-05-14 | Recordati S.A. Chemical And Pharmaceutical Company | Thienopyranecarboxamide derivatives |
US6306861B1 (en) | 1999-07-30 | 2001-10-23 | Recordati S.A. Chemical And Pharmaceutical Company | Thienopyrancecarboxamide derivatives |
IT1313581B1 (it) * | 1999-07-30 | 2002-09-09 | Recordati Chem Pharm | Derivati tienopirancarbossamidici. |
IT1314192B1 (it) * | 1999-10-18 | 2002-12-06 | Recordati Chem Pharm | Derivati benzopiranici |
US6403594B1 (en) | 1999-10-18 | 2002-06-11 | Recordati, S.A. Chemical And Pharmaceutical Company | Benzopyran derivatives |
KR100333500B1 (ko) * | 2000-01-19 | 2002-04-25 | 박호군 | 아릴피페라진 화합물 및 그의 제조방법 |
TW200400035A (en) | 2002-03-28 | 2004-01-01 | Glaxo Group Ltd | Novel compounds |
EA200401335A1 (ru) * | 2002-04-08 | 2006-02-24 | Ранбакси Лабораторис Лимитед | Производные карбоксимида в качестве уроселективных блокаторов альфа-1a адренорецепторов |
US7030122B2 (en) * | 2002-04-12 | 2006-04-18 | Sepracor Inc. | 1,4-disubstituted piperazine ligands for neurotransmitter receptors |
US20040058962A1 (en) * | 2002-06-14 | 2004-03-25 | Amedeo Leonardi | Phenylalkylamines and pyridylalkylamines |
US20040072839A1 (en) * | 2002-06-14 | 2004-04-15 | Amedeo Leonardi | 1-Phenylalkylpiperazines |
US20040215284A1 (en) * | 2003-01-30 | 2004-10-28 | Recordati S.A. | Treatment of neuromuscular dysfunction of the lower urinary tract with selective mGlu5 antagonists |
ITMI20030151A1 (it) * | 2003-01-30 | 2004-07-31 | Recordati Ind Chimica E Farma Ceutica S P A | Uso di antagonisti selettivi del recettore mglu5 per il trattamento di disfunzioni neuromuscolari del tratto urinario inferiore. |
TW200507841A (en) * | 2003-03-27 | 2005-03-01 | Glaxo Group Ltd | Antibacterial agents |
US20050165025A1 (en) * | 2004-01-22 | 2005-07-28 | Recordati Ireland Ltd. | Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists |
TWI391387B (zh) * | 2004-05-12 | 2013-04-01 | Eisai R&D Man Co Ltd | 具有哌啶環之吲哚衍生物 |
US20080119518A1 (en) * | 2005-02-04 | 2008-05-22 | Yuichi Suzuki | 1-(Piperidin-4- Yl)-1H-Indole Derivatives |
AU2006244916B2 (en) | 2005-05-11 | 2011-04-07 | Eisai R & D Management Co., Ltd. | Method for producing indole derivative having piperidine ring |
AU2006244914A1 (en) * | 2005-05-11 | 2006-11-16 | Eisai R & D Management Co., Ltd. | Crystal of indole derivative having piperidine ring and process for production thereof |
JPWO2006121104A1 (ja) * | 2005-05-11 | 2008-12-18 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピペリジン環を有するインドール誘導体の結晶およびその製法 |
JP4932717B2 (ja) * | 2005-05-11 | 2012-05-16 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピペリジン環を有するインドール誘導体の製造方法 |
CN101175751B (zh) * | 2005-05-11 | 2011-03-23 | 卫材R&D管理有限公司 | 具有哌啶环的吲哚衍生物的晶体和其制备方法 |
US7671221B2 (en) * | 2005-12-28 | 2010-03-02 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
CA2856037C (en) * | 2005-12-28 | 2017-03-07 | Vertex Pharmaceuticals Incorporated | Modulators of atp-binding cassette transporters |
CN103360342B (zh) * | 2012-04-09 | 2015-12-16 | 江苏恩华药业股份有限公司 | 3-氰基苯胺烷基芳基哌嗪衍生物及在制备药物中的应用 |
CN113402467B (zh) * | 2021-06-18 | 2022-05-13 | 山东汇海医药化工有限公司 | 一种氟班色林的合成方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3362956A (en) * | 1965-08-19 | 1968-01-09 | Sterling Drug Inc | 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines |
US3635976A (en) * | 1967-12-20 | 1972-01-18 | Pennwalt Corp | 1 - heterocyclic alkyl-1 2 3 4-tetrahydroquinazolinones and analgesic intermediates thereof |
JPS49101383A (pt) * | 1973-02-05 | 1974-09-25 | ||
US4017624A (en) * | 1973-02-05 | 1977-04-12 | Sumitomo Chemical Company, Limited | N-(ω-Amino)alkylaniline derivatives |
US5008267A (en) * | 1988-10-29 | 1991-04-16 | Mitsui Toatsu Chemicals, Incorporated | Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same |
JPH0413669A (ja) * | 1990-04-27 | 1992-01-17 | Mitsui Toatsu Chem Inc | 新規ピリミジンジオン誘導体及び該化合物を含有する抗不整脈剤 |
EP0598123A4 (en) * | 1991-07-19 | 1995-02-15 | Zeria Pharm Co Ltd | PIPERAZINE DERIVATIVE AND MEDICINAL PRODUCT CONTAINING THE SAME. |
GB9200293D0 (en) * | 1992-01-08 | 1992-02-26 | Wyeth John & Brother Ltd | Piperazine derivatives |
IT1266582B1 (it) * | 1993-07-30 | 1997-01-09 | Recordati Chem Pharm | Derivati (di)azacicloesanici e diazacicloeptanici |
GB9411099D0 (en) * | 1994-06-03 | 1994-07-27 | Wyeth John & Brother Ltd | Piperazine derivatives |
US5688795A (en) * | 1994-11-08 | 1997-11-18 | Syntex (U.S.A.) Inc. | 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists |
-
1997
- 1997-08-01 IT IT97MI001864A patent/IT1293807B1/it active IP Right Grant
-
1998
- 1998-07-31 CA CA002297095A patent/CA2297095A1/en not_active Abandoned
- 1998-07-31 NZ NZ502804A patent/NZ502804A/xx unknown
- 1998-07-31 KR KR1020007001096A patent/KR20010022509A/ko not_active Application Discontinuation
- 1998-07-31 AT AT98943815T patent/ATE256671T1/de not_active IP Right Cessation
- 1998-07-31 EP EP98943815A patent/EP1000047B1/en not_active Expired - Lifetime
- 1998-07-31 JP JP2000505143A patent/JP2001512112A/ja active Pending
- 1998-07-31 HU HU0004926A patent/HUP0004926A3/hu unknown
- 1998-07-31 BR BR9811482-4A patent/BR9811482A/pt not_active IP Right Cessation
- 1998-07-31 WO PCT/EP1998/004804 patent/WO1999006384A1/en not_active Application Discontinuation
- 1998-07-31 CN CN98807820A patent/CN1127493C/zh not_active Expired - Fee Related
- 1998-07-31 PL PL98338352A patent/PL338352A1/xx unknown
- 1998-07-31 US US09/127,057 patent/US6071920A/en not_active Expired - Fee Related
- 1998-07-31 IL IL13408998A patent/IL134089A0/xx unknown
- 1998-07-31 DE DE69820632T patent/DE69820632D1/de not_active Expired - Lifetime
- 1998-07-31 AU AU91578/98A patent/AU737456B2/en not_active Ceased
- 1998-07-31 RU RU2000105266/04A patent/RU2199533C2/ru not_active IP Right Cessation
-
2000
- 2000-02-01 NO NO20000521A patent/NO315232B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1999006384A1 (en) | 1999-02-11 |
IL134089A0 (en) | 2001-04-30 |
ITMI971864A1 (it) | 1999-02-01 |
IT1293807B1 (it) | 1999-03-10 |
HUP0004926A3 (en) | 2002-01-28 |
PL338352A1 (en) | 2000-10-23 |
NO20000521L (no) | 2000-02-01 |
KR20010022509A (ko) | 2001-03-15 |
US6071920A (en) | 2000-06-06 |
AU9157898A (en) | 1999-02-22 |
NO20000521D0 (no) | 2000-02-01 |
EP1000047B1 (en) | 2003-12-17 |
JP2001512112A (ja) | 2001-08-21 |
CN1265654A (zh) | 2000-09-06 |
HUP0004926A2 (hu) | 2001-11-28 |
EP1000047A1 (en) | 2000-05-17 |
ATE256671T1 (de) | 2004-01-15 |
DE69820632D1 (de) | 2004-01-29 |
RU2199533C2 (ru) | 2003-02-27 |
NZ502804A (en) | 2001-02-23 |
CA2297095A1 (en) | 1999-02-11 |
CN1127493C (zh) | 2003-11-12 |
AU737456B2 (en) | 2001-08-23 |
NO315232B1 (no) | 2003-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9811482A (pt) | Derivados de 1-(n-fenilaminoalquil)-piperazina substituìda na posição 2 do anel fenìlico | |
BRPI0411255A (pt) | composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto | |
BG103417A (en) | Condensed pyrimidine bicyclic derivatives | |
BR9810592A (pt) | Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto | |
BRPI0007487B8 (pt) | difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase | |
BRPI0307351B8 (pt) | composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto | |
HK1044527A1 (zh) | 對位取代的苯乙烯衍生物和其作為整合素劑的用途 | |
BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
MX9707453A (es) | Derivados de quinazolina. | |
WO2002024700A3 (en) | SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES | |
WO1999057117A3 (de) | Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen | |
TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
YU11501A (sh) | Derivati 4,4,-biarilpiperidina sa aktivnošću na receptor opijata | |
ATE311179T1 (de) | Verwendungen und zusammensetzungen zur behandlung von primären und sekundären tumoren des zentralnervensystems (zns) | |
AP9701041A0 (en) | Pyridylpyrrole compounds. | |
BR0215151A (pt) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6 | |
BRPI0110024B8 (pt) | derivados de ecteinascidina antitumorais, composição farmacêutica que os compreende e uso dos mesmos | |
BR0314353A (pt) | Compostos, composições farmacêuticas, uso de um ou mais compostos em combinação com outros compostos farmacologicamente ativos, e, método para tratar um paciente que sofre de um distúrbio | |
DE69838662D1 (de) | Morphinanderivate und ihre medizinische Anwendung | |
SE9903997D0 (sv) | New compounds | |
BR0011831A (pt) | Compostos, processo para preparar os mesmos, composições farmacêuticas, e, uso dos compostos | |
BR0012169A (pt) | Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia | |
TR200103457T2 (tr) | 4-Fenil-Pirimidin Türevleri. | |
UY26426A1 (es) | Nuevos compuestos | |
SE9902267D0 (sv) | New compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1890 DE 27/03/2007. |